GlobalData on MSN
BD secures FDA 510(k) clearance for EnCor EnCompass system
BD expects to bring the system to market in early 2026.
BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue removal system.
SALT LAKE CITY--(BUSINESS WIRE)--3M Health Information Systems is expanding its market-leading 3M 360 Encompass System platform to introduce 3M 360 Encompass System – Professional, the industry’s ...
Becton, Dickinson and CompanyBDX, popularly known as BD, recently announced that the FDA has granted 510(k) clearance for its ...
FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug ...
The 3M™ 360 Encompass™ System seamlessly integrates CAC, CDI, concurrent quality metrics, and analytics to capture, analyze, and advance patient information across the continuum of care SANTA CLARA, ...
3M Health Information Systems has added 3M 360 Encompass System – Professional, an encounter-based professional fee coding solution, to its 3M 360 Encompass System platform. Here are three things to ...
(RTTNews) - Becton, Dickinson and Co. (BDX) today announced that the U.S. FDA has granted 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System, a next-generation device ...
Franklin Lakes, New Jersey Saturday, January 17, 2026, 10:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results